Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Netherlands
/
Materials
/
DSM-Firmenich
DSFIR
DSM-Firmenich
Regulatory And Merger Challenges Will Constrain Benefits But Spark Growth
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 20 Analysts
Published
10 Aug 25
Updated
10 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€87.45
6.0% undervalued
intrinsic discount
10 Aug
€82.18
Loading
1Y
-30.1%
7D
-0.4%
Author's Valuation
€87.5
6.0% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€87.5
6.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-254m
13b
2014
2017
2020
2023
2025
2026
2028
Revenue €13.5b
Earnings €694.5m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
3.17%
Chemicals revenue growth rate
0.35%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
5.89%
Calculation
€694.47m
Earnings '28
x
38.42x
PE Ratio '28
=
€26.68b
Market Cap '28
€26.68b
Market Cap '28
/
259.05m
No. shares '28
=
€103.00
Share Price '28
€103.00
Share Price '28
Discounted to 2025 @ 5.89% p.a.
=
€86.76
Fair Value '25